Medmira Inc. Stock
Price
Target price
€0.050
€0.050
-2.940%
-0.0015
-2.940%
-
18.09.24 / Stuttgart Stock Exchange
WKN: 932414 / Name: MedMira / Stock / Healthcare Equipment & Supplies / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Medmira Inc. Stock
A loss of -2.940% shows a downward development for Medmira Inc..
Pros and Cons of Medmira Inc. in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medmira Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medmira Inc. | -2.940% | 3.125% | -9.174% | -10.811% | -23.846% | - | - |
| Theralase Technologies Inc | -3.400% | -0.500% | -9.545% | -34.967% | -4.327% | -22.266% | -30.662% |
| Atossa Genetics Inc | 0.460% | -6.686% | 10.499% | 73.163% | 36.451% | -57.763% | -30.557% |
| NetScientific plc | -0.850% | 0.000% | -4.918% | -9.375% | -4.918% | -54.688% | -4.918% |
News
Clinical Trials to get Underway with Multiplo® Complete Syphilis (TP/nTP) Antibody Test - A Potential Game Changer to Address Syphilis Health Crisis in Canada
Halifax, Nova Scotia, 13 August, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces it will conduct full clinical trials for its unique Multiplo® Complete Syphilis (TP/nTP) Antibody
MedMira Announces the Hire of Vice President of Business Development
Halifax, Nova Scotia, 30 April, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to announce the expansion of their commercialisation team by welcoming Ms. Rene Bell to the
MedMira gibt Einstellung eines Vizepräsidenten für Geschäftsentwicklung bekannt
Halifax, Nova Scotia, 30 April, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to announce the expansion of their commercialisation team by welcoming Ms. Rene Bell to the